What Happened
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Why It Matters
This development may influence policy, markets, and public sentiment based on how events unfold.
Background Context
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
What To Watch Next
Track official statements, independent verification, and regional impact updates in the next 24 to 48 hours.
Editorial Next Step
Add your local context, fact checks, quotes, and analysis before or after publication.
Source: BBC News – Original Link
Source: BBC News
